iRhythm Announces Approval of $200 Million Share Repurchase Program
iRhythm's board approved a share repurchase program authorizing up to $200 million of common stock, announced November 11, 2026. The company framed the buyback as reflecting confidence in its core business and growth opportunities from the recently acquired VitalConnect business.
Key figures
- Deal Value Usd
- 200000000
- Approval date
- 2026-11-10
- Buyback authorization
- $200 million
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.